Author: Dr Gavin Esson, Foundation Trainee, NHS Lothian, Edinburgh, Scotland. DermNet NZ Editor in Chief: Adjunct A/Prof. Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell/Maria McGivern. December 2018.
Hypogonadism describes the inadequate function of the gonads (reproductive glands) leading to impaired production of germ cells and sex hormones.
Hypogonadism in males refers to diminished testicular function — a reduction in sperm production and in testosterone.
Hypogonadism is due to disruption to any section of the hypothalamic–pituitary–gonadal axis pathway (figure 1).
FSH; follicle-stimulating hormone, GnRH; gonadotropin-releasing hormone, LH; luteinising hormone
Both primary and secondary hypogonadism in males may be congenital or acquired.
Signs of congenital primary hypogonadism includes:
Acquired primary hypogonadism may be result of:
Congenital secondary hypogonadism results from isolated gonadotropin deficiency due to genetic mutations, such as Kallmann syndrome, Prader–Willi syndrome, and other similar conditions.
Acquired secondary hypogonadism may result from:
The clinical features of hypogonadism depend on the patient's age at presentation.
Hypogonadism at birth may be recognised by ambiguous genitalia (external genitals that are neither clearly male nor clearly female).
Hypogonadism pre-puberty may be diagnosed by the failure to undergo or complete puberty. The boy may have a young appearance, lack pubic hair, have small genitalia and testes, his voice may fail to break, and he may have difficulty in gaining muscle.
After the completion of puberty, the features of hypogonadism include decreased libido, erectile dysfunction, osteoporosis, depression, gynaecomastia, shrinking of the testes, and infertility. After some years of testosterone deficiency, decreased muscle mass and body hair may be evident.
Androgens are responsible for sebaceous gland growth and differentiation, hair growth, and epidermal barrier homeostasis .
Androgen deficiency results in:
The diagnosis of hypogonadism is based on observing typical clinical features in a man with low serum testosterone. The patient should be referred to a specialist.
Initial investigations should include measuring LH, FSH, and serum testosterone (usually taken in the morning, and repeated at least twice). If testosterone is low:
Further investigations should be directed at identifying the underlying cause.
Effective testosterone replacement in men with hypogonadism has been showed to maintain secondary sexual characteristics, increase libido, muscle strength, fat-free mass, and bone density .
Adverse effects of testosterone replacement include:
Testosterone should not be started in individuals with breast cancer, prostate cancer or an increased risk of prostate cancer, haematocrit above 50%, untreated obstructive sleep apnoea, severe lower urinary tract symptoms, or uncontrolled heart failure .
See the DermNet NZ bookstore.
© 2019 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.